|
Malyavin A.G., Mkrtumyan A.M., Adasheva T.V., Bolieva L.Z.
Prediabetes: Therapy of carbohydrate metabolism disorders in patients with risk factors
|
№9 / 2024
|
|
Lukina Yu.V., Zagrebelny A.V., Kutishenko N.P., Voronina V.P., Martsevich S.Yu., Shepel R.N., Drapkina O.M.
Bene dignoscitur, bene curatur: Analysis of implementation of diagnostic and therapeutic measures for pre-diabetes management in clinical practice conditions (according to the data of the REGION-M hospital and outpatient register)
|
№9 / 2024
|
|
Teplova, A.S. Demidova T.Yu., Lobanova K.G.
Peculiarities of outpatient glycemic profile of patients with type 2 diabetes mellitus during innovative sugar-reducing therapy combined with metformin according to flash glucose monitoring data
|
№9 / 2023
|
|
Granovskaya M.V., Demidova T.Yu., Zaslavskaya K.Ya., Balykova L.A.
Targeted therapy of COVID-19 in ambulatory-polyclinical practice
|
№8 / 2020
|
|
T.Yu. Demidova, D.V. Skuridina, Ya.V. Pugovkina
Targets and modern strategy of therapy for different groups of patients with type 2 diabetes mellitus
|
№5 / 2017
|
|
A.S. Ametov, D.G. Gusenbekova
Treatment of type 2 diabetes mellitus using fixed combination of metformin and glibenclamide
|
№4 / 2017
|
|
T.Yu. Demidova, I.N. Drozdova
Metformin: review of current evidence and international recommendations
|
№2 / 2017
|
|
T.Yu. Demidova
Oral hypoglycemic therapy in the practice of a general practitioner
|
№6 / 2016
|
|
T.Yu. Demidova
Sulfonylurea derivatives in the light of evidence-based medicine and algorithms of diabetes mellitus type 2
|
№4 / 2016
|
|
I.V. Druk, Ye.A. Ryapolova
Metformin: updated guidance and pleiotropic potential
|
№4 / 2016
|
|
I.V. Poluboyarinova, V.V. Fadeev
A new look at the effects of metformin
|
№1 / 2016
|
|
L.V. Nedosugova
Current place of metformin in the treatment of type 2 diabetes
|
№4 / 2015
|
Русский
